Melissa Dupree
Family · Americus, GANPI 1326601071
Payments from drug & device makers
Across 152 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$588
- AbbVie$526
- GSK$523
- AstraZeneca$252
- Lilly USA, LLC$142
- Corcept Therapeutics$124
- plus $431 from 12 others
What the payments were for
- Food & beverage$2,585100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $588 |
| AbbVie | 31 | $526 |
| GSK | 29 | $523 |
| AstraZeneca | 14 | $252 |
| Lilly USA, LLC | 7 | $142 |
| Corcept Therapeutics | 5 | $124 |
| Xeris Pharmaceuticals, Inc. | 3 | $63 |
| Amgen | 4 | $58 |
| Ardelyx, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $38 |
| Exact Sciences | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$118
How this compares
$2,585 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 121 | $115,040 |
| OzempicSemaglutide | 67 | $100,628 |
| MounjaroTirzepatide | 79 | $93,903 |
| TrulicityDulaglutide | 43 | $55,296 |
| EliquisApixaban | 48 | $54,099 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $47,433 |
| VraylarCariprazine Hcl | 33 | $45,612 |
| Invega SustennaPaliperidone Palmitate | 11 | $40,280 |
| FarxigaDapagliflozin Propanediol | 51 | $39,130 |
| LinzessLinaclotide | 35 | $36,382 |
| MyrbetriqMirabegron | 37 | $29,627 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $27,976 |
| JanuviaSitagliptin Phosphate | 19 | $19,546 |
| TradjentaLinagliptin | 13 | $17,316 |
| QuliptaAtogepant | 14 | $16,578 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $142 | $149,199122 claims |
| Boehringer IngelheimJardiance, Tradjenta | $38 | $132,356134 claims |
| Novo NordiskOzempic, Wegovy | $588 | $115,31378 claims |
| AbbVieVraylar, Linzess, Qulipta | $526 | $98,57282 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $252 | $70,837101 claims |
| GSKTrelegy Ellipta | $523 | $47,43357 claims |
| MerckJanuvia | $15 | $19,54619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.
Other family in Americus
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.